{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:27:28Z","timestamp":1783024048295,"version":"3.54.6"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    A 32-year-old woman with metastatic papillary thyroid carcinoma, confirmed to harbor an NCOA4-RET fusion and progressing to radioiodine-refractory status, was initiated on selpercatinib. Following 10 months of treatment, serial thyroglobulin (Tg) measurements and post-therapeutic\n                    <jats:sup>131<\/jats:sup>\n                    I scans after recombinant human TSH stimulation were performed. The scans demonstrated restored diffuse radioiodine uptake in previously refractory lung metastases, accompanied by a significant decline in Tg levels. This case illustrates that selpercatinib can induce effective redifferentiation in RET-altered radioiodine-refractory thyroid cancer, enabling successful radioiodine therapy.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006431","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:03:22Z","timestamp":1783022602000},"page":"659-660","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Selpercatinib-induced Redifferentiation and Enhanced Radioiodine Uptake in Radioiodine-refractory Thyroid Cancer"],"prefix":"10.1097","volume":"51","author":[{"given":"Zizhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6488-6232","authenticated-orcid":false,"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"e240369","DOI":"10.1530\/ETJ-24-0369","article-title":"TSHR in thyroid cancer: bridging biological insights to targeted strategies","volume":"14","author":"Xu","year":"2025","journal-title":"Eur Thyroid J"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3892\/etm.2025.12898","article-title":"Successful surgical management of a patient with osteoradionecrosis of the jaw with RET fusion-positive advanced thyroid cancer: a case report","volume":"30","author":"Kimura","year":"2025","journal-title":"Exp Ther Med"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2967\/jnumed.124.268539","article-title":"Redifferentiation of a RET-fusion, radioiodine-refractory, differentiated thyroid cancer with selpercatinib: flip-flop between [18F]FDG PET\/CT and 131I posttreatment scanning","volume":"66","author":"Barbry","year":"2025","journal-title":"J Nucl Med"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamaoncol.2021.6268","article-title":"Apatinib vs placebo in patients with locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: the REALITY randomized clinical trial","volume":"8","author":"Lin","year":"2022","journal-title":"JAMA Oncol"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3803\/EnM.2019.34.3.215","article-title":"Radioactive iodine-refractory differentiated thyroid cancer and redifferentiation therapy","volume":"34","author":"Liu","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"e240219","DOI":"10.1530\/ERC-24-0219","article-title":"Efficacy and safety of RET-kinase inhibitors in RET-altered thyroid cancers: a systematic review and single-arm meta-analysis","volume":"32","author":"Riya","year":"2025","journal-title":"Endocr Relat Cancer"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S2213-8587(25)00064-6","article-title":"Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement","volume":"13","author":"Leboulleux","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"e240332","DOI":"10.1530\/ETJ-24-0332","article-title":"Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?","volume":"14","author":"Porcelli","year":"2025","journal-title":"Eur Thyroid J"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:03:24Z","timestamp":1783022604000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006431"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006431","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"2025-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}